Bèlgica - anglès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cheplapharm arzneimittel gmbh - mefloquine hydrochloride 274,09 mg - eq. mefloquine 250 mg - tablet - 250 mg - mefloquine 250 mg - mefloquine

Singapur - anglès - HSA (Health Sciences Authority)

roche singapore pte. ltd. - mefloquine hcl eqv mefloquine base - tablet - 250 mg

Estats Units - anglès - NLM (National Library of Medicine)

almatica pharma inc. - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 60 mg - fluoxetine tablets are indicated for the treatment of: the use of maois intended to treat psychiatric disorders with fluoxetine or within 5 weeks of stopping treatment with fluoxetine is contraindicated because of an increased risk of serotonin syndrome. the use of fluoxetine within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated [see dosage and administration (2.6) and warnings and precautions (5.2)] . starting fluoxetine in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome [see dosage and administration ( 2.7) and warnings and precautions (5.2)] . the use of fluoxetine is contraindicated with the following: pimozide and thioridazine prolong the qt interval. fluoxetine can increase the levels of pimozide and thioridazine through inhibition of cyp2d6. fluoxetine can also prolong the qt interval. pregnancy exposure registry there is a pregnancy exposure

Kenya - anglès - Pharmacy and Poisons Board

acino pharma ag birsweg 2 liesberg basel ��� land - artesunate+mefloquine - oral powder in sachet - 50 mg artesunate 125 mg mefloquine - antimalarial antiprotozoals: plain artemisininand

Kenya - anglès - Pharmacy and Poisons Board

acino pharma ag birsweg 2 liesberg basel ��� land - artesunate+mefloquine - film-coated tablet - artesunate 200 mg mefloquine 250 mg - antimalarial antiprotozoals: plain artemisininand

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

roche products limited - mefloquine hydrochloride - tablets - 250 base milligrams

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - mefloquine hydrochloride - oral tablet - 250mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - mefloquine hydrochloride - oral tablet - 250mg

Kenya - anglès - Pharmacy and Poisons Board

acino pharma ag birsweg 2 4253 liesberg switzerland - mefloquine - film-coated tablet - 250 mg mefloquine base (corresponding to 275 mg… - antimalarial antiprotozoals: methanolquinolines

Malta - anglès - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - mefloquine - tablet - mefloquine 250 mg - antiprotozoals